Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05045157 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders

Study acronym: SECOIA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 90 to confirmed 50
    • Site details revised at 4 of 4 sites
    v13
  2. Study Identification, Study Status, Oversight, Contacts/Locationsv12
  3. Site contacts updated at 1 of 4 sitesv11
  4. Site contacts updated at 1 of 4 sitesv10
  5. Primary completion date: Sep 30, 2024 to May 31, 2026
    • Study completion date: Sep 30, 2025 to May 31, 2027
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Eligibility criteria expanded, about 7 wordsv8
  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2022 to May 31, 2022
    • Site details revised at 4 of 4 sites
    v6
  4. Start date: Mar 31, 2022 to Sep 1, 2022
    • Primary completion date: Nov 30, 2024 to Sep 30, 2024
    • Study completion date: Nov 30, 2025 to Sep 30, 2025
    v5
  5. Start date: Jan 31, 2022 to Mar 31, 2022v4
  6. Start date: Nov 1, 2021 to Jan 31, 2022v3
  7. Start date: Oct 1, 2021 to Nov 1, 2021
    • Primary completion date: Oct 31, 2024 to Nov 30, 2024
    • Study completion date: Oct 31, 2025 to Nov 30, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Trigger finger is a mechanical problem characterized by pain and catching of digit in flexion. Histological changes of A1 pulley and synovial proliferation have been identified as factors that prompt trigger finger The first-line treatment of trigger finger is conservative with splinting and corticosteroid injection. If the first infiltration fails, either a second infiltration or surgical sectioning of the pulley is proposed. Surgery can be performed by several techniques (open section, percutaneous section with palpatory guidance, or under ultrasound guidance). Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by a percutaneous insertion with small needle under local anaesthesia. The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance followed by a corticosteroid injection would be more effective than a second corticosteroid injection alone on complete resolution of the trigger finger symptoms
Trial Details
NCT Number NCT05045157
Lead Sponsor Centre Hospitalier Departemental Vendee
Conditions
(from sponsor)		 Trigger Finger
Related terms Trigger Finger Disorder
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov